Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Jim Cramer: Lemonade Is 'Up Too Much,' This Health Care Stock Can Go Lower
JMP Securities analyst Ronald Josey maintained Lemonade with a Market Outperform and raised the price target from $40 to $60.
Jim Cramer says to stay focused on earnings reports after Wednesday's stock rally
CNBC’s Jim Cramer examined Wednesday’s market rally and stressed that it’s important to stay focused on corporate earnings and commentary from management.
Jim Cramer says he supports healthcare stocks for their long-term value
CNBC’s Jim Cramer stresses the importance of investing for the long term, highlighting healthcare stocks Eli Lilly, Merck and Regeneron.
5d
on MSN
Jim Cramer on Moderna, Inc. (MRNA): ‘The Numbers Here Are Staggering, Staggeringly Bad’
We recently compiled a list of the 10 S&P 500 Stocks on Jim Cramer’s Radar. In this article, we are going to take a look at ...
Finbold | Finance in Bold
15d
Here’s how much you could’ve made with $1,000 on Jim Cramer’s top 2 picks
Jim Cramer is known for his seemingly ill-timed stock recommendations but how have his two most favored investments fared in ...
5d
on MSN
Jim Cramer explains why DraftKings is a buy through the NFL's playoffs
CNBC’s Jim Cramer on Friday told investors why he thinks it’s a good time to buy sports betting platform DraftKings, whose ...
4d
on MSN
Jim Cramer Says Vertiv Holdings (VRT) is ‘Very High’
We recently published a list of Jim Cramer’s Latest Lightning Round: Top 10 Stocks. In this article, we are going to take a ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback